Crossref Membership & DOI(Digital Object Identifier) Registration
Supporting persistent identification, structured scholarly metadata, research discoverability, citation linking, and long-term access to published scholarly content.
The Advances in Obesity, Endocrinology, and Diabetes has access to Crossref DOI services through the Crossref Sponsor Model. The journal receives administrative and technical assistance for its Crossref DOI activities through GetDOI.com , a specialised Digital Object Identifier (DOI) service platform operated by Sequence Research and Development Private Limited .
The sponsorship arrangement helps scholarly journals and publishing organisations access Crossref services while receiving technical and administrative support for DOI registration, metadata submission, DOI management, and related scholarly publishing activities. For more information about Crossref's Sponsor model, please visit the official Crossref information on working with a Sponsor .
Persistent DOI
Persistent identification for eligible scholarly publications.
Structured Metadata
Bibliographic metadata connected with the scholarly record.
Global Connectivity
Connect obesity, endocrinology, diabetes, metabolic health, and interdisciplinary biomedical research with the wider scholarly ecosystem.
Digital Object Identifier (DOI) Services Through GetDOI.com
GetDOI.com provides Crossref DOI sponsorship and technical support services for scholarly journals, publishers, research organisations, universities, academic institutions, and scholarly publishing initiatives.
Through the service, journals such as the Advances in Obesity, Endocrinology, and Diabetes can receive assistance with DOI registration, metadata submission, DOI management, and technical integration with journal publishing platforms. GetDOI.com is a service initiative of Sequence Research and Development Private Limited , a research publishing technology and infrastructure service provider.
Visit GetDOI.comAbout DOI Registration
The Advances in Obesity, Endocrinology, and Diabetes participates in the Crossref DOI registration infrastructure to support the persistent identification, citation, discoverability, and linking of scholarly content published by the journal.
The journal supports research and scholarly contributions related to obesity, endocrinology, diabetes mellitus, metabolic syndrome, insulin resistance, glucose metabolism, lipid disorders, thyroid diseases, pituitary and adrenal disorders, reproductive endocrinology, nutrition, bariatric medicine, diabetic complications, cardiovascular-metabolic health, endocrine pharmacology, preventive medicine, clinical research, and related biomedical and interdisciplinary health sciences.
Crossref provides scholarly metadata infrastructure that enables publishers and scholarly organisations to register Digital Object Identifiers and connect research outputs through persistent metadata records.
Purpose of DOI Registration
For Published Articles
✓ Persistent identification of published scholarly content
✓ DOI-based linking to article landing pages
✓ Structured scholarly metadata registration
✓ Improved interoperability with scholarly infrastructure
For Obesity, Endocrinology & Diabetes Research Discovery
✓ Better citation linking and metadata discoverability
✓ Long-term identification of endocrine, diabetes, obesity, and metabolic research outputs
✓ Support for accurate bibliographic and publication metadata
✓ Improved connectivity across scholarly, clinical, biomedical, and research discovery services
Article Publication
The scholarly article is prepared and published by Advances in Obesity, Endocrinology, and Diabetes.
Metadata Preparation
Article and bibliographic metadata are prepared for DOI registration.
DOI Registration
Eligible publication metadata is submitted through the Crossref DOI registration infrastructure.
Persistent Linking
The DOI resolves to the journal's published article landing page.
Journal Publishing Platform
The Advances in Obesity, Endocrinology, and Diabetes operates its scholarly publishing workflow through a digital journal management and publishing platform.
DOI-related metadata can be incorporated into the journal's article publishing workflow and displayed on individual article pages.
DOI information provides authors, endocrinologists, diabetologists, obesity researchers, metabolic health specialists, clinicians, biomedical scientists, readers, libraries, institutions, and indexing services with a persistent reference to the published scholarly record.
DOI Display & Metadata
✓ DOI displayed prominently on article landing pages
✓ DOI included in article metadata
✓ Correct article URL connected with the DOI record
✓ Author, article title, publication date, volume, issue, and bibliographic metadata maintained accurately
✓ DOI information included in citation information where applicable
Supporting Modern Journal Publishing With ScholarJMS
Modern scholarly journals require an organised digital workflow for manuscript submission, editorial evaluation, peer review, publication, metadata management, and research dissemination. Platforms such as ScholarJMS can support journals in managing these publishing activities within a structured digital environment.
For journals publishing research across obesity, endocrinology, diabetes, metabolic syndrome, insulin resistance, thyroid disorders, nutrition, cardiovascular-metabolic health, endocrine diseases, clinical medicine, preventive healthcare, and related biomedical sciences, an organised journal management system can help maintain accurate article titles, authorship information, publication dates, article URLs, citation details, and bibliographic metadata throughout the publishing workflow.
Crossref www.crossref.org Need Crossref DOI or Journal Management Support?
Get assistance with Crossref DOI sponsorship, DOI registration, scholarly metadata management, publishing infrastructure, and modern journal workflow technology for academic and research journals.
Crossref DOI services for the Advances in Obesity, Endocrinology, and Diabetes are facilitated through GetDOI.com [+91 82003 85143] by Sequence Research and Development Private Limited .